GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » Total Assets

RAJAF (Cordyceps Sunshine Biotech Holdings Co) Total Assets : $3.42 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co Total Assets?

Cordyceps Sunshine Biotech Holdings Co's Total Assets for the quarter that ended in Dec. 2023 was $3.42 Mil.

During the past 12 months, Cordyceps Sunshine Biotech Holdings Co's average Total Assets Growth Rate was 62.40% per year. During the past 3 years, the average Total Assets Growth Rate was 6.40% per year.

During the past 4 years, Cordyceps Sunshine Biotech Holdings Co's highest 3-Year average Total Assets Growth Rate was 6.40%. The lowest was 6.40%. And the median was 6.40%.

Total Assets is connected with ROA %. Cordyceps Sunshine Biotech Holdings Co's annualized ROA % for the quarter that ended in Dec. 2023 was 149.12%. Total Assets is also linked to Revenue through Asset Turnover. Cordyceps Sunshine Biotech Holdings Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.12.

Cordyceps Sunshine Biotech Holdings Co Total Assets Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co Total Assets Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Assets
2.83 3.26 2.11 3.42

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
Dec20 Dec21 Sep22 Dec22 Sep23 Dec23
Total Assets Get a 7-Day Free Trial 3.26 - 2.11 1.80 3.42

Cordyceps Sunshine Biotech Holdings Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cordyceps Sunshine Biotech Holdings Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=-0.079+3.501
=3.42

Cordyceps Sunshine Biotech Holdings Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=-0.079+3.501
=3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cordyceps Sunshine Biotech Holdings Co  (OTCPK:RAJAF) Total Assets Explanation

Total Assets is connected with ROA %.

Cordyceps Sunshine Biotech Holdings Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=3.892/( (1.798+3.422)/ 2 )
=3.892/2.61
=149.12 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cordyceps Sunshine Biotech Holdings Co's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.316/( (1.798+3.422)/ 2 )
=0.316/2.61
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cordyceps Sunshine Biotech Holdings Co Total Assets Related Terms

Thank you for viewing the detailed overview of Cordyceps Sunshine Biotech Holdings Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordyceps Sunshine Biotech Holdings Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » Total Assets
Comparable Companies
Traded in Other Exchanges
N/A
Address
Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN
Website
http://www.cordyceps-sunshine.com
Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines